Mirae Asset Global Investments
AVXL icon

Mirae Asset Global Investments’s Anavex Life Sciences AVXL Stock Holding History

Mirae Asset Global Investments’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.7K Sell
4,145
-689
-14% -$2.04K ﹤0.01% 1567
2026
Q1 		$14.8K Buy
4,834
+492
+11% +$2.13K ﹤0.01% 1461
2025
Q4 		$15.5K Buy
4,342
+1,021
+31% +$6.25K ﹤0.01% 1566
2025
Q3 		$29.6K Buy
3,321
+23
+0.7% +$233 ﹤0.01% 1438
2025
Q2 		$30.4K Buy
3,298
+452
+16% +$3.86K ﹤0.01% 1330
2025
Q1 		$24.8K Buy
2,846
+20
+0.7% +$189 ﹤0.01% 1364
2024
Q4 		$34.2K Sell
2,826
-241
-8% -$1.85K ﹤0.01% 1331
2024
Q3 		$17.4K Buy
3,067
+540
+21% +$3.12K ﹤0.01% 1451
2024
Q2 		$10.8K Sell
2,527
-52,323
-95% -$212K ﹤0.01% 1456
2024
Q1 		$383K Buy
54,850
+12,728
+30% +$71.6K ﹤0.01% 2010
2023
Q4 		$392K Sell
42,122
-683
-2% -$4.7K ﹤0.01% 2086
2023
Q3 		$280K Sell
42,805
-3,187
-7% -$25.4K ﹤0.01% 2156
2023
Q2 		$371K Sell
45,992
-5,732
-11% -$49.1K ﹤0.01% 2082
2023
Q1 		$443K Buy
51,724
+17,579
+51% +$175K ﹤0.01% 1985
2022
Q4 		$316K Buy
34,145
+4,507
+15% +$48.1K ﹤0.01% 2133
2022
Q3 		$306K Buy
29,638
+8,641
+41% +$91.2K ﹤0.01% 2148
2022
Q2 		$210K Buy
+20,997
New +$199K ﹤0.01% 2134

Other funds holding AVXL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Mirae Asset Global Investments's AVXL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Anavex Life Sciences (AVXL) stake by 14% in Q2 2026, selling an estimated $2.04K and leaving 4,145 shares worth $10.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1567.

Mirae Asset Global Investments first reported a position in AVXL in Q2 2022 and has held it in 17 quarters since. The position peaked at $443K in Q1 2023. 179 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • Mirae Asset Global Investments held 4,145 shares of Anavex Life Sciences worth $10.7K as of Q2 2026.
  • Mirae Asset Global Investments sold 689 Anavex Life Sciences shares in Q2 2026, an estimated $2.04K.
  • Anavex Life Sciences made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1567 holding.
  • Mirae Asset Global Investments first reported a position in Anavex Life Sciences in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Anavex Life Sciences position peaked at $443K in Q1 2023.
  • 179 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.